Amy C. Peterson Cytom X Therapeutics, Inc. (CTMX) insider trading activity

Amy C. Peterson is EVP, Chief Development Officer of CytomX Therapeutics, Inc.. Currently has a direct ownership of 58,433 shares of CTMX, which is worth approximately $217,370. The most recent transaction as insider was on Mar 16, 2023, when has been sold 4,257 shares (Common Stock) at a price of $1.98 per share, resulting in proceeds of $8,428. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 58.4K

0% 3M change

0% 12M change

Total Value Held $217,370

Amy C. Peterson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 16 2023	SELL Open market or private sale	$8,428 $1.98 p/Share	4,257 Reduced 6.79%	58,433 Common Stock
Jul 20 2022	SELL Open market or private sale	$10,597 $1.42 p/Share	7,463 Reduced 10.64%	62,690 Common Stock
Jul 19 2022	BUY Grant, award, or other acquisition	-	20,000 Added 22.18%	70,153 Common Stock
Feb 02 2022	BUY Grant, award, or other acquisition	-	40,000 Added 46.29%	46,421 Common Stock
May 31 2021	BUY Grant, award, or other acquisition	$20,219 $6.09 p/Share	3,320 Added 34.08%	6,421 Common Stock
Nov 30 2020	BUY Grant, award, or other acquisition	$19,815 $6.39 p/Share	3,101 Added 50.0%	3,101 Common Stock

Also insider at

EXEL

EXELIXIS, INC. Healthcare

EVP Prod Dev & Med Aff & CMO

ACP

Amy C. Peterson

EVP, Chief Development Officer

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CTMX shares.

Notify only if

Value

Insider Trading

Get notified when an Cytom X Therapeutics, Inc. insider buys or sells CTMX shares.

Notify only if

Operation

Value

Type

News

Receive news related to CytomX Therapeutics, Inc.

Track Activities on CTMX

Account